169 related articles for article (PubMed ID: 29865054)
1. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.
Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M
J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
[TBL] [Abstract][Full Text] [Related]
3. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.
Fairley LH; Sahara N; Aoki I; Ji B; Suhara T; Higuchi M; Barron AM
J Neuroinflammation; 2021 Mar; 18(1):76. PubMed ID: 33740987
[TBL] [Abstract][Full Text] [Related]
5. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
6. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
[TBL] [Abstract][Full Text] [Related]
8. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
[TBL] [Abstract][Full Text] [Related]
9. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
[TBL] [Abstract][Full Text] [Related]
10. Iso-α-Acids, the Bitter Components of Beer, Suppress Microglial Inflammation in rTg4510 Tauopathy.
Ano Y; Takaichi Y; Uchida K; Kondo K; Nakayama H; Takashima A
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501069
[TBL] [Abstract][Full Text] [Related]
11. Intersection of pathological tau and microglia at the synapse.
Vogels T; Murgoci AN; Hromádka T
Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
[TBL] [Abstract][Full Text] [Related]
12. PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy.
Benetatos J; Bennett RE; Evans HT; Ellis SA; Hyman BT; Bodea LG; Götz J
Acta Neuropathol; 2020 Jul; 140(1):7-24. PubMed ID: 32236736
[TBL] [Abstract][Full Text] [Related]
13. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
[TBL] [Abstract][Full Text] [Related]
14. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
[TBL] [Abstract][Full Text] [Related]
15. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice.
Ruan Z; Delpech JC; Venkatesan Kalavai S; Van Enoo AA; Hu J; Ikezu S; Ikezu T
Mol Neurodegener; 2020 Aug; 15(1):47. PubMed ID: 32811520
[TBL] [Abstract][Full Text] [Related]
16. p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model.
Perea JR; García E; Vallés-Saiz L; Cuadros R; Hernández F; Bolós M; Avila J
Sci Rep; 2022 Feb; 12(1):2130. PubMed ID: 35136118
[TBL] [Abstract][Full Text] [Related]
17. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK.
Li Y; Munoz-Mayorga D; Nie Y; Kang N; Tao Y; Lagerwall J; Pernaci C; Curtin G; Coufal NG; Mertens J; Shi L; Chen X
Cell Metab; 2024 Jun; 36(6):1351-1370.e8. PubMed ID: 38657612
[TBL] [Abstract][Full Text] [Related]
18. Tau oligomers as potential targets for early diagnosis of tauopathy.
Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice.
Kunze LH; Ruch F; Biechele G; Eckenweber F; Wind-Mark K; Dinkel L; Feyen P; Bartenstein P; Ziegler S; Paeger L; Tahirovic S; Herms J; Brendel M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373253
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
